Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 62

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Chemotactic And Chemokinetic Properties Of Topical Ophthalmic Therapeutic Agents In Uveitis Patients

M.E. Zajdenweber; E. Antecka; J. Deschenes; K. Godeiro; P. Ozdal; M.G. Baines; M.N. Burnier

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4520.

ARVO Annual Meeting Abstract May 2006

Immunohistochemical Panel for the Identification of Poorly Differentiated Orbital Metastatic Tumors

K.D. Godeiro; A.N. Odashiro; N. Gans; S. Callejo; D.N. Odashiro; M.N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4687.

ARVO Annual Meeting Abstract May 2006

Histopathological Findings and Immunohistochemical Expression of Vimentin, Cytokeratin 8 and Cytokeratin 18 in Freeze–Dried and Fresh–Frozen Preserved Human Amniotic Membranes

A.T. Dias; M. Martins; A.A. S. L. Filho; A.N. Odashiro; A.C. S. Lourenco; J.P. Gomes; R. Belfort, Jr.; M.N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5049.

ARVO Annual Meeting Abstract May 2006

The Relationship Between Multiple Pregnancy and Incidence of Retinopathy of Prematurity

M. Motta; C.A. Fiorot; B.F. Fernandes; A.C. Frota; V.S. Saraiva; M.N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5308.

ARVO Annual Meeting Abstract May 2006

In vitro Characterization of Vascular Loops in Four Uveal Melanoma Cell Lines

F.J. Gregoire; B.F. Fernandes; J.–C.A. Marshall; S. Di Cesare; E. Antecka; M.N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5330.

ARVO Annual Meeting Abstract May 2006

Immunohistochemical Expression of Prostatic–Specific Membrane Antigen in Choroidal Neovascular Membranes of Patients With ARMD

A.C. Frota; K.D. Godeiro, V; S.C. Maloney; A. Al–Kandari; J. Cools– Lartigue; M.N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):862.

ARVO Annual Meeting Abstract May 2006

Immunomagnetic Isolation From Blood of Five Human Uveal Melanoma Cell Lines

J.J. Cools–Lartigue; C.S. McCauley; F.J. Gregoire; J.–C.A. Marshall; C. Edelstein; M.N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2216.

ARVO Annual Meeting Abstract May 2006

The Effect of a Cox–2 Inhibitor on an Ocular Melanoma Animal Model

M.N. Burnier, Jr.; J.–C.A. Marshall; F.J. Gregoire; S. Di Cesare; P. Logan; A. Al–Kandari

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2218.

ARVO Annual Meeting Abstract May 2006

Migratory and Immunohistochemical Analysis of 5 Human Uveal Melanoma Cell Lines Towards CXCL–12, CXCL–8, CXCL–1, and HGF

S. Di Cesare; P. Logan; J.C. Marshall; F.J. Gregoire; D. Faingold; M.N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2229.

ARVO Annual Meeting Abstract May 2006

In vivo Imaging of Fluorescently Labeled Human Uveal Melanoma Cells in Nude Mice

P. Logan; J.–C.A. Marshall; B.F. Fernandes; S. Maloney; V. Saraiva; M.N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2230.

ARVO Annual Meeting Abstract May 2006

Expression of Cytokeratins 8 and 18 in Human Melanoma Cells Obtained From a Rabbit Model of Uveal and Cutaneous Melanoma

S.C. Maloney; S. Bakalian; A.B. T. Dias; K.D. Godeiro; E. Antecka; M.N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2231.

ARVO Annual Meeting Abstract May 2006

Transcriptional Profiling of Circulating Malignant Cells Isolated From an Animal Model of Uveal Melanoma

J.–C.A. Marshall; A. Nantel; P.L. Blanco; J. Ash; M.N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2235.

ARVO Annual Meeting Abstract May 2006

Immunohistochemical Expression of Melanocytic Markers in Irradiated Uveal Melanoma

B.F. Fernandes; A.N. Odashiro; V.S. Saraiva; A. Al–Kandari; S. Bakalian; M.N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2237.

ARVO Annual Meeting Abstract May 2006

The Immunohistochemical Expression of CCR6 in Primary Human Uveal Melanoma

V. Bravo; K. Godeiro; C. Esmerado; D. Faingold; E. Antecka; M.N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2240.

ARVO Annual Meeting Abstract May 2006

The Effect of Curcumin on the Proliferation Rate of Human Uveal Melanoma Cell Lines

S. Bakalian; J.C. Marshal; D. Faingold; P. Logan; A.C. Frota; M.N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2246.

ARVO Annual Meeting Abstract May 2006

Immune Expression and Inhibition of Hsp90 in Human Uveal Melanoma

D. Faingold; J.–C. Marshall; S. Bakalian; A. Al–Kandari; C. Edelstein; M.N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2247.

ARVO Annual Meeting Abstract May 2006

Iris Melanoma Originating From an Iris Nevus

A.A. Al–Kandari; B. Fernandes; S. Maloney; C. Edelstien; J. Deschenes; M.N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2251.

ARVO Annual Meeting Abstract May 2006

The Combination of Azathioprine and Corticosteroids in the Treatment of Serpiginous Choroiditis

R.N. Vianna; P.C. Ozdal; J. Deschênes; M.N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2423.

ARVO Annual Meeting Abstract May 2006

Expression and Inhibition of P–Glycoprotein in Retinoblastoma Cell Lines

C.S. McCauley; D. Faingold; J.–C.A. Marshall; S. Di Cesare; S. Bakalian; M.N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2804.

ARVO Annual Meeting Abstract May 2005

Chemotactic Properties of Topical Medications for Glaucoma

M.P. Ventura; H.P. Solari; E. Antecka; N.E. Saheb; M.G. Baines; M.N. Burnier, Jr

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1284.

1 2 3 4

Next 20 Results »

Advertisement